Indicator bacteriophage for selecting and monitoring for efficacy of therapeutics and methods for using same
AssigneeLaboratory Corporation of America Holdings
InventorsJOSE S. GIL, STEPHEN ERICKSON, MINH MINDY BAO NGUYEN, DWIGHT LYMAN ANDERSON
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods and systems for detection of microorganisms in a sample and the utilization of such methods for selecting and monitoring therapies. The specificity of indicator bacteriophage, such as Staphylococcus-specific bacteriophage, allows detection of a specific microorganism, such as Staphylococcus and the indicator signal may be amplified to optimize assay sensitivity.
Claims23
-15. (canceled)
A method for detecting Staphylococcus in a sample comprising:
- incubating the sample with a recombinant bacteriophage derived from Staphylococcus-specific bacteriophage comprising an indicator gene inserted into a late gene region of the bacteriophage genome;
- and
- detecting an indicator protein product produced by the recombinant bacteriophage, wherein positive detection of the indicator protein product indicates that Staphylococcus is present in the sample,
- wherein incubating the sample with the recombinant bacteriophage is performed at a temperature of at least about 25 degrees Celsius (C) and no greater than about 45 degrees C.
A system for detecting Staphylococcus comprising a recombinant bacteriophage derived from Staphylococcus-specific bacteriophage.
-32. (canceled)
A method for selecting a treatment for a subject comprising:
- (i) obtaining a biological sample from the subject;
- (ii) detecting a specific microorganism or category of microorganisms in the biological sample using an indicator phage;
- and
- (iii) selecting a treatment based on the identity of a specific microorganism detected in the biological sample.
(canceled)
Dependencies are inferred from the claim text.